KORU Medical Systems, Inc.
Moat Score — KORU Medical Systems, Inc.
Total Moat Score
11 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 3 / 5 | KORU's FREEDOM System design and its stated position as the U.S. market leader in mechanical large-volume subcutaneous infusion for PIDD/CIDP reflect real, defensible device IP and regulatory clearances built up over years. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 2 / 5 | Fully mechanical pumps that need no batteries or electricity are inherently simpler and cheaper to manufacture than electronic volumetric pumps, giving KORU a real cost-structure edge in its core category. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 2 / 5 | Market leadership in a clinically entrenched therapy area supports steady pricing, but heavy reliance on distributors (77% of revenue, one at ~29%) gives those channel partners real negotiating leverage back against KORU. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | There is no network effect in selling infusion pumps - clinical adoption is driven by physician familiarity and patient outcomes, not by other users making the product more valuable. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 3 / 5 | Patients and clinicians trained on and accustomed to the FREEDOM System face real switching costs - retraining, new supply relationships, and clinical comfort with a different delivery mechanism - once established on the platform. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 1 / 5 | The company's ~$119 million market value and reliance on a handful of distributors show it operates at a modest scale within a fragmented, multi-technology infusion device market rather than commanding a scale-driven barrier to entry. |